Boenning & Scattergood’s GSK GSK Stock Holding History

Boenning & Scattergood’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.88M	Buy	43,255 +5,813	+16%	+$194K	0.3%	87
2022 Q3	$1.1M	Buy	37,442 +7,910	+27%	+$300K	0.23%	114
2022 Q2	$1.61M	Sell	29,532 -5,072	-15%	-$280K	0.3%	83
2022 Q1	$1.88M	Sell	34,604 -11,164	-24%	-$606K	0.3%	87
2021 Q4	$2.52M	Sell	45,768 -2,292	-5%	-$119K	0.4%	61
2021 Q3	$2.29M	Buy	48,060 +4,096	+9%	+$206K	0.4%	61
2021 Q2	$2.19M	Buy	43,964 +7,468	+20%	+$359K	0.38%	70
2021 Q1	$1.63M	Buy	36,496 +2,222	+6%	+$101K	0.31%	91
2020 Q4	$1.58M	Buy	34,274 +1,552	+5%	+$71.3K	0.33%	84
2020 Q3	$1.54M	Sell	32,722 -1,540	-4%	-$77.2K	0.37%	70
2020 Q2	$1.75M	Sell	34,262 -4,797	-12%	-$246K	0.47%	54
2020 Q1	$1.85M	Sell	39,059 -1,102	-3%	-$58.8K	0.64%	39
2019 Q4	$2.36M	Buy	40,161 +14,632	+57%	+$814K	0.61%	43
2019 Q3	$1.36M	Buy	25,529 +44	+0.2%	+$2.26K	0.39%	67
2019 Q2	$1.27M	Buy	25,485 +135	+0.5%	+$6.77K	0.37%	77
2019 Q1	$1.32M	Sell	25,350 -18,699	-42%	-$934K	0.4%	72
2018 Q4	$2.1M	Buy	44,049 +18,294	+71%	+$901K	0.73%	30
2018 Q3	$1.29M	Sell	25,755 -46	-0.2%	-$2.34K	0.41%	66
2018 Q2	$1.3M	Buy	+25,801	New	+$1.3M	0.43%	68

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Boenning & Scattergood's GSK Position: Q4 2022 in Review

Boenning & Scattergood increased its GSK (GSK) stake by 16% in Q4 2022, buying an estimated $194K and bringing the position to 43,255 shares worth $1.88M. The position accounts for 0.3% of the portfolio, ranked #87.

Boenning & Scattergood first reported a position in GSK in Q2 2018 and has held it in 19 quarters since. The position peaked at $2.52M in Q4 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Boenning & Scattergood held 43,255 shares of GSK worth $1.88M as of Q4 2022.
Boenning & Scattergood bought 5,813 GSK shares in Q4 2022, an estimated $194K.
GSK made up 0.3% of Boenning & Scattergood's portfolio in Q4 2022, its #87 holding.
Boenning & Scattergood first reported a position in GSK in Q2 2018 and has held it in 19 quarters since.
Boenning & Scattergood's GSK position peaked at $2.52M in Q4 2021.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.